-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Jörn Jörgensen Is The Founder of EuroEyes International Eye Clinic Limited (HKG:1846) And Just Spent HK$1.3m On Shares
Jörn Jörgensen Is The Founder of EuroEyes International Eye Clinic Limited (HKG:1846) And Just Spent HK$1.3m On Shares
Investors who take an interest in EuroEyes International Eye Clinic Limited (HKG:1846) should definitely note that the Founder, Jörn Jörgensen, recently paid HK$5.04 per share to buy HK$1.3m worth of the stock. Although the purchase is not a big one, by either a percentage standpoint or absolute value, it can be seen as a good sign.
Check out our latest analysis for EuroEyes International Eye Clinic
EuroEyes International Eye Clinic Insider Transactions Over The Last Year
Notably, that recent purchase by Founder Jörn Jörgensen was not the only time they bought EuroEyes International Eye Clinic shares this year. They previously made an even bigger purchase of HK$1.3m worth of shares at a price of HK$6.59 per share. That means that an insider was happy to buy shares at above the current price of HK$4.96. Their view may have changed since then, but at least it shows they felt optimistic at the time. In our view, the price an insider pays for shares is very important. As a general rule, we feel more positive about a stock if insiders have bought shares at above current prices, because that suggests they viewed the stock as good value, even at a higher price.
EuroEyes International Eye Clinic insiders may have bought shares in the last year, but they didn't sell any. You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date!
SEHK:1846 Insider Trading Volume September 19th 2022There are plenty of other companies that have insiders buying up shares. You probably do not want to miss this free list of growing companies that insiders are buying.
Insider Ownership Of EuroEyes International Eye Clinic
Another way to test the alignment between the leaders of a company and other shareholders is to look at how many shares they own. I reckon it's a good sign if insiders own a significant number of shares in the company. EuroEyes International Eye Clinic insiders own about HK$927m worth of shares (which is 56% of the company). This kind of significant ownership by insiders does generally increase the chance that the company is run in the interest of all shareholders.
What Might The Insider Transactions At EuroEyes International Eye Clinic Tell Us?
It is good to see the recent insider purchase. And the longer term insider transactions also give us confidence. Along with the high insider ownership, this analysis suggests that insiders are quite bullish about EuroEyes International Eye Clinic. Looks promising! Therefore, you should definitely take a look at this FREE report showing analyst forecasts for EuroEyes International Eye Clinic.
But note: EuroEyes International Eye Clinic may not be the best stock to buy. So take a peek at this free list of interesting companies with high ROE and low debt.
For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
对以下内容感兴趣的投资者 EuroEyes 国际眼科诊所有限公司 (HKG: 1846)一定要注意,创始人约恩·约根森最近以每股5.04港元的价格购买了价值130万港元的股票。尽管从百分比或绝对价值的角度来看,收购并不大,但可以看作是一个好兆头。
查看我们对 EuroEyes 国际眼科诊所的最新分析
EuroEyes 国际眼科诊所去年内幕交易
值得注意的是,创始人约恩·约根森最近的收购并不是他们今年唯一一次购买EuroEyes International Eye Clinic的股票。此前,他们以每股6.59港元的价格购买了价值130万港元的股票。这意味着内部人士乐于以高于当前4.96港元的价格购买股票。从那以后,他们的看法可能发生了变化,但至少这表明他们当时感到乐观。在我们看来,内部人士为股票支付的价格非常重要。通常,如果内部人士以高于当前的价格买入股票,我们对股票的看法会更加乐观,因为这表明他们认为股票物有所值,即使价格更高。
EuroEyes International Eye Clinic的内部人士可能在去年购买了股票,但他们没有卖出任何股票。您可以在下面看到过去12个月内幕交易(公司和个人)的直观描述。如果你点击图表,你可以看到所有的个人交易,包括股价、个人和日期!
联交所:1846 2022年9月19日内幕交易量还有很多其他公司有内部人士买入股票。你可能这样做 不 想错过这个 免费的 内部人士正在收购的成长型公司名单。
EuroEyes 国际眼科诊所的内部所有权
测试公司领导者与其他股东之间一致性的另一种方法是查看他们拥有多少股票。我认为,如果内部人士拥有该公司的大量股份,那将是一个好兆头。EuroEyes International Eye Clinic内部人士拥有价值约9.27亿港元的股份(占该公司的56%)。内部人士的这种重要所有权通常会增加公司为了所有股东的利益而经营的机会。
EuroEyes 国际眼科诊所的内幕交易会告诉我们什么?
很高兴看到最近的内幕收购。而长期的内幕交易也给我们带来了信心。除了内部人士的高所有权外,该分析还表明,内部人士非常看好EuroEyes International Eye Clinic。看起来很有希望!因此,你一定要看看这个 免费 报告显示了分析师对EuroEyes国际眼科诊所的预测。
但请注意: EuroEyes 国际眼科诊所可能不是最值得买入的股票。所以来看看这个 免费的 投资回报率高、负债低的有趣公司名单。
就本文而言,内部人士是指向相关监管机构报告交易的个人。我们目前用于公开市场交易和私人处置,但不包括衍生品交易。
对这篇文章有反馈吗?担心内容吗? 取得联系 直接和我们联系。 或者,给编辑团队 (at) simplywallst.com 发送电子邮件。
Simply Wall St 的这篇文章本质上是笼统的。 我们仅使用公正的方法根据历史数据和分析师的预测提供评论,我们的文章无意作为财务建议。 它不构成买入或卖出任何股票的建议,也没有考虑您的目标或财务状况。我们的目标是为您提供由基本面数据驱动的长期重点分析。请注意,我们的分析可能不考虑最新的价格敏感公司公告或定性材料。简而言之,华尔街在上述任何股票中都没有头寸。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧